ALK-Abelló A/S
ALK-B
株式のランク
#2340
ALK-Abelló A/S is a global leader in allergy solutions, with operations... ALK-Abelló A/S is a global leader in allergy solutions, with operations spanning Europe, North America, and other international regions. The company offers a comprehensive portfolio of treatments for allergic rhinitis and allergic asthma, featuring key products such as GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX. ALK-Abelló specializes in allergy immunotherapy, providing options like injections, sublingual drops, and tablets to address a wide range of sensitivities, including those to grass, ragweed, house dust mites, Japanese cedar, various tree pollens, and certain foods. Furthermore, the company engages with consumers through a digital healthcare ecosystem, a platform designed to connect with allergy sufferers early in their journey, offering tools, e-commerce solutions, and guidance to support and streamline access to immunotherapy. ALK-Abelló also provides essential diagnostic allergy services, including skin prick and blood tests, alongside emergency treatments such as intramuscular adrenaline injections for severe, life-threatening allergic reactions like anaphylaxis. The company was established in 1923 and is based in Hørsholm, Denmark.
株価
$37.79
時価総額
$8.38B
変化（1日）
0.00%
変化（1年）
12.73%
国
DK
取引 ALK-Abelló A/S (ALK-B)
カテゴリー
Healthcare
ALK-Abelló A/S（ALK-B）の配当利回りの履歴
ALK-Abelló A/S（銘柄コード: ALK-B）の配当利回り（TTM）は2023-12-31時点で0.00%です。
過去5年間の平均配当利回り: 0.00%
過去5年間の平均配当利回り: 0.00%
ALK-Abelló A/S（ALK-B）の2004から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2026 (TTM) | 0.71% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | -100.00% |
| 2017 | 0.69% | 27.78% |
| 2016 | 0.54% | -6.90% |
| 2015 | 0.58% | -28.40% |
| 2014 | 0.81% | -5.81% |
| 2013 | 0.86% | -32.81% |
| 2012 | 1.28% | -18.47% |
| 2011 | 1.57% | 0.00% |
| 2010 | 1.57% | 27.64% |
| 2009 | 1.23% | -80.63% |
| 2008 | 6.35% | 1,948.39% |
| 2007 | 0.31% | -99.41% |
| 2006 | 52.37% | 24,838.10% |
| 2005 | 0.21% | -57.14% |
| 2004 | 0.49% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.17% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
